VIRALYNK DIAGNOSTICS LLP

In their own words

1. To research, develop, manufacture, validate, commercialize, and distribute molecular diagnostic assays, kits, reagents, and devices for the detection of infectious diseases including but not limited to dengue virus, using RT-LAMP, PCR, isothermal amplification, CRISPR-based diagnostics, and other nucleic acid amplification technologies. 2. To develop and supply affordable, rapid, decentralized diagnostic solutions including extraction-free molecular testing platforms suitable for Primary Health Centres, rural health facilities, field laboratories, and low-resource settings. 3. To provide diagnostic services, laboratory testing, disease surveillance support, and molecular epidemiology solutions for public health agencies, hospitals, clinics, research institutions, and private entities. 4. To undertake translational research and convert laboratory innovations into commercially viable healthcare products. 5. To collaborate with government bodies, public health institutions, universities, biotechnology companies, hospitals, and international organizations for disease surveillance and outbreak response.

Written by the company on its public Startup India profile. Not verified by us.